Kay NE - Search Results

1

Kay NE. Kay NE. Leuk Res. 2007 Nov;31(11):1459-60. doi: 10.1016/j.leukres.2007.04.001. Epub 2007 May 16. Leuk Res. 2007. PMID: 17509682 No abstract available.

2

Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia.

Kini AR, Kay NE, Peterson LC. Kini AR, et al. Among authors: kay ne. Leukemia. 2000 Aug;14(8):1414-8. doi: 10.1038/sj.leu.2401825. Leukemia. 2000. PMID: 10942237

3

Angiogenesis in B-chronic lymphocytic leukemia.

Kay NE, Jelinek DF, Peterson L. Kay NE, et al. Leuk Res. 2001 Jun;25(6):485-6. doi: 10.1016/s0145-2126(01)00008-x. Leuk Res. 2001. PMID: 11337021 No abstract available.

4

Angiogenesis in B-chronic lymphocytic leukemia.

Kay NE, Jelinek DF, Peterson L. Kay NE, et al. Leuk Res. 2001 Aug;25(8):709-10. doi: 10.1016/s0145-2126(01)00002-9. Leuk Res. 2001. PMID: 11397477 No abstract available.

5

B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.

Kay NE, Bone ND, Tschumper RC, Howell KH, Geyer SM, Dewald GW, Hanson CA, Jelinek DF. Kay NE, et al. Leukemia. 2002 May;16(5):911-9. doi: 10.1038/sj.leu.2402467. Leukemia. 2002. PMID: 11986954

6

CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL.

Pittner BT, Jelinek DF, Kay NE. Pittner BT, et al. Among authors: kay ne. Leukemia. 2004 Jan;18(1):180-2. doi: 10.1038/sj.leu.2403151. Leukemia. 2004. PMID: 14523466 No abstract available.

7

The angiogenic status of B-CLL B cells: role of the VEGF receptors.

Kay NE. Kay NE. Leuk Res. 2004 Mar;28(3):221-2. doi: 10.1016/j.leukres.2003.10.014. Leuk Res. 2004. PMID: 14687614 No abstract available.

8

VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.

Lee YK, Shanafelt TD, Bone ND, Strege AK, Jelinek DF, Kay NE. Lee YK, et al. Among authors: kay ne. Leukemia. 2005 Apr;19(4):513-23. doi: 10.1038/sj.leu.2403667. Leukemia. 2005. PMID: 15703780

9

A recombinant IL-4-Pseudomonas exotoxin inhibits protein synthesis and overcomes apoptosis resistance in human CLL B cells.

Kay NE, Bone ND, Lee YK, Jelinek DF, Leland P, Battle TE, Frank DA, Puri RK. Kay NE, et al. Leuk Res. 2005 Sep;29(9):1009-18. doi: 10.1016/j.leukres.2004.11.025. Epub 2005 Apr 12. Leuk Res. 2005. PMID: 16038727

10

MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?

Shanafelt TD, Kay NE, Call TG, Zent CS, Jelinek DF, LaPlant B, Morice WG, Hanson CA. Shanafelt TD, et al. Among authors: kay ne. Leuk Res. 2008 Sep;32(9):1458-61. doi: 10.1016/j.leukres.2007.11.030. Epub 2008 Jan 7. Leuk Res. 2008. PMID: 18179821 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

460 results

Search Page

Filters